LeadingLogo.png
Leading BioSciences Announces Positive Topline Data from Open-Label Gastrointestinal Surgery Study
08 janv. 2021 08h30 HE | Leading BioSciences
CARLSBAD, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Leading BioSciences, Inc. (“LBS”), a privately held company that recently entered into a definitive agreement for a reverse merger with Seneca...
LeadingLogo.png
Leading BioSciences Receives IND Clearance for Phase 2 COVID-19 Study
15 mai 2020 09h00 HE | Leading BioSciences
CARLSBAD, Calif., May 15, 2020 (GLOBE NEWSWIRE) -- Leading BioSciences, Inc. (LBS), a drug development company focused on improving human health through therapeutic protection of the intestinal...
LeadingLogo.png
Leading BioSciences Announces Potential for Investigational Drug LB1148 to Treat Multiple Organ Dysfunction Syndrome in COVID-19 Patients
07 avr. 2020 09h00 HE | Leading BioSciences
CARLSBAD, Calif., April 07, 2020 (GLOBE NEWSWIRE) -- Leading BioSciences, a drug development company focused on improving human health through therapeutic protection of the intestinal mucosal...
LeadingLogo.png
Leading BioSciences Announces Top Line Phase 2 Data Demonstrating LB1148 Achieves Primary Endpoint with Statistically Significant Improvement in Bowel Function Following Cardiovascular Surgery
24 mars 2020 09h35 HE | Leading BioSciences
CARLSBAD, Calif., March 24, 2020 (GLOBE NEWSWIRE) -- Leading BioSciences, a drug development company focused on improving human health through therapeutic protection of the intestinal mucosal...
LeadingLogo.png
Leading BioSciences to Present at Planet MicroCap Showcase 2019
25 avr. 2019 08h05 HE | Leading BioSciences
CARLSBAD, Calif., April 25, 2019 (GLOBE NEWSWIRE) -- Leading BioSciences, a drug development company focused on improving human health through therapeutic protection of the Gastrobiome™, today...
LeadingLogo.png
Leading BioSciences to Present at Biotech Showcase 2019
02 janv. 2019 08h05 HE | Leading BioSciences
CARLSBAD, Ca., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Leading BioSciences, a drug development company focused on improving human health through therapeutic protection of the Gastrobiome™, today announced...
LeadingLogo.png
Leading BioSciences Announces Appointments of James R. Neal and James Sapirstein to Board of Directors
30 oct. 2018 08h05 HE | Leading BioSciences
Experienced Industry Executives Provide Company with Broad Life Science Industry Expertise Including Drug Development and Commercialization CARLSBAD, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) --...
Leading BioSciences
Leading BioSciences Reports Positive Interim Results from Phase 2 Trial of LB1148 in Patients Undergoing Major Surgery
19 juin 2018 07h05 HE | Leading BioSciences
CARLSBAD, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- Leading BioSciences, a drug development company focused on improving human health through therapeutic protection of the Gastrobiome™, today...